Pilot Study Evaluating THERAVEX Tissue Care Spray Plus for Healing Wounds, Burns, and Chronic Ulcers

What this Trial Is About

Researchers are evaluating the safety and potential effectiveness of THERAVEX Tissue Care Spray Plus as an additional topical treatment for managing various types of skin wounds, including burns, traumatic wounds, pressure ulcers, diabetic foot ulcers, and other chronic ulcers. This pilot observational study involves 26 adult patients and focuses on how the spray may support the natural healing process of skin wounds by improving tissue regeneration and reducing inflammation. The treatment involves applying the mineral-based THERAVEX Tissue Care Spray Plus directly onto the cleaned wound surface alongside standard wound care practices. The spray is designed to help restore the wound environment by promoting tissue hydration, epithelial regeneration, granulation tissue formation, and reducing signs of inflammation. Patients receive this combined treatment during the study period. Participants undergo regular medical evaluations and photographic documentation to monitor wound healing progression up to 12 weeks. Researchers assess tissue hydration, inflammation, wound appearance, and local tolerance to the spray. They also observe any adverse events or allergic reactions. The study aims to gather preliminary data to support further controlled research on this wound care approach.

THERAVEX Tissue Care Spray Plus for the Management of Cutaneous Wounds, Burns, and Chronic Ulcers